188 related articles for article (PubMed ID: 10802004)
1. von Willebrand factor, fibrinogen, and soluble P-selectin levels after mitral valve replacement versus mitral valve repair.
Goldsmith IR; Blann AD; Patel RL; Lip GY
Am J Cardiol; 2000 May; 85(10):1218-22. PubMed ID: 10802004
[TBL] [Abstract][Full Text] [Related]
2. Increased platelet activation and endothelial dysfunction in patients with atrial fibrillation immediately following percutaneous balloon mitral valvuloplasty.
Goldsmith IR; Foo LS; Blann AD; Lip GY
Clin Cardiol; 2000 Aug; 23(8):587-90. PubMed ID: 10941544
[TBL] [Abstract][Full Text] [Related]
3. Effect of aortic valve replacement on plasma soluble P-selectin, von Willebrand factor, and fibrinogen.
Goldsmith IR; Blann AD; Patel RL; Lip GY
Am J Cardiol; 2001 Jan; 87(1):107-10, A9. PubMed ID: 11137845
[TBL] [Abstract][Full Text] [Related]
4. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.
Lip GY; Blann AD; Zarifis J; Beevers M; Lip PL; Beevers DG
J Hypertens; 1995 Dec; 13(12 Pt 2):1674-8. PubMed ID: 8903631
[TBL] [Abstract][Full Text] [Related]
5. von Willebrand Factor Abnormalities and Heyde Syndrome in Dysfunctional Heart Valve Prostheses.
Blackshear JL; McRee CW; Safford RE; Pollak PM; Stark ME; Thomas CS; Rivera CE; Wysokinska EM; Chen D
JAMA Cardiol; 2016 May; 1(2):198-204. PubMed ID: 27437891
[TBL] [Abstract][Full Text] [Related]
6. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.
Li-Saw-Hee FL; Blann AD; Gurney D; Lip GY
Eur Heart J; 2001 Sep; 22(18):1741-7. PubMed ID: 11511124
[TBL] [Abstract][Full Text] [Related]
7. Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Spencer CG; Gurney D; Blann AD; Beevers DG; Lip GY;
Hypertension; 2002 Jul; 40(1):61-6. PubMed ID: 12105139
[TBL] [Abstract][Full Text] [Related]
8. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
[TBL] [Abstract][Full Text] [Related]
9. Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor.
Blann AD; Gurney D; Wadley M; Bareford D; Stonelake P; Lip GY
Blood Coagul Fibrinolysis; 2001 Jan; 12(1):43-50. PubMed ID: 11229826
[TBL] [Abstract][Full Text] [Related]
10. Decreased platelet activation and endothelial dysfunction after percutaneous mitral balloon valvuloplasty.
Yetkin E; Erbay AR; Turhan H; Ileri M; Ayaz S; Atak R; Senen K; Cehreli S
Int J Cardiol; 2003 Oct; 91(2-3):221-5. PubMed ID: 14559134
[TBL] [Abstract][Full Text] [Related]
11. Indexes of hypercoagulability measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation secondary to mitral stenosis.
Li-Saw-Hee FL; Blann AD; Goldsmith I; Lip GY
Am J Cardiol; 1999 Apr; 83(8):1206-9. PubMed ID: 10215285
[TBL] [Abstract][Full Text] [Related]
12. A cross-sectional, diurnal, and follow-up study of platelet activation and endothelial dysfunction in malignant phase hypertension.
Lip GY; Edmunds E; Hee FL; Blann AD; Beevers DG
Am J Hypertens; 2001 Aug; 14(8 Pt 1):823-8. PubMed ID: 11497201
[TBL] [Abstract][Full Text] [Related]
13. Atrial endocardial changes in mitral valve disease: a scanning electron microscopy study.
Goldsmith I; Kumar P; Carter P; Blann AD; Patel RL; Lip GY
Am Heart J; 2000 Nov; 140(5):777-84. PubMed ID: 11054625
[TBL] [Abstract][Full Text] [Related]
14. Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation.
Lip GY; Pearce LA; Chin BS; Conway DS; Hart RG
Heart; 2005 Jun; 91(6):759-63. PubMed ID: 15894770
[TBL] [Abstract][Full Text] [Related]
15. Left atrial endocardial dysfunction and platelet activation in patients with atrial fibrillation and mitral stenosis.
Luo ZQ; Hao XH; Li JH; Dai J; Liu KY; Lai YQ
J Thorac Cardiovasc Surg; 2014 Nov; 148(5):1970-6. PubMed ID: 24412254
[TBL] [Abstract][Full Text] [Related]
16. Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy.
Gibbs CR; Blann AD; Watson RD; Lip GY
Circulation; 2001 Apr; 103(13):1746-51. PubMed ID: 11282905
[TBL] [Abstract][Full Text] [Related]
17. Effect of acute exercise on the raised plasma fibrinogen, soluble P-selectin and von Willebrand factor levels in chronic atrial fibrillation.
Li-Saw-Hee FL; Blann AD; Edmunds E; Gibbs CR; Lip GY
Clin Cardiol; 2001 May; 24(5):409-14. PubMed ID: 11346250
[TBL] [Abstract][Full Text] [Related]
18. High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction.
Lee KW; Blann AD; Lip GY
Am J Hypertens; 2005 Jan; 18(1):104-15. PubMed ID: 15691624
[TBL] [Abstract][Full Text] [Related]
19. A pilot study of streptokinase-induced endothelial injury and platelet activation following acute myocardial infarction.
Lip GY; Lydakis C; Nuttall SL; Landray MJ; Watson RD; Blann AD
J Intern Med; 2000 Oct; 248(4):316-8. PubMed ID: 11086642
[TBL] [Abstract][Full Text] [Related]
20. Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure.
Freestone B; Gustafsson F; Chong AY; Corell P; Kistorp C; Hildebrandt P; Lip GY
Chest; 2008 May; 133(5):1203-8. PubMed ID: 18339785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
